Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Skip to content
Mitochondrial Disease News logo
  • Treatments
    Experimental Treatments
    • Elamipretide (MTP-131)
    • KL1333
    • Lumevoq (GS010)
    • NVP015
  • News
  • Health Insights
  • FAQs
  • What can we help you find today?

January 12, 2018 by Larry Luxner

Parents of Mito Children Often Face False Medical Abuse Charges, Patient Advocates Claim

Justina Pelletier, a Connecticut teenager with mitochondrial disease, was admitted to Boston Children’s Hospital in 2013 on the advice of a metabolic geneticist at nearby Tufts Medical Center so she could see her longtime gastroenterologist, who had recently transferred to Boston. But the hospital — without consulting the Tufts…

Recent Posts

  • COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
  • Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe
  • Unity and EU-wide Efforts Focus of Online Rare Disease Meeting
  • Vitamin B3 Boosts Muscle Health in Mitochondrial Myopathy, Study Suggests
  • Rare Diseases Clinical Research Network Opens Online Survey on COVID-19
Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: 1-800-936-1363

  • Publishing Team
  • Leadership
  • Our Culture
  • Corrections Policy
  • Advertising Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.